BARCLAYS PLC

Position in DNLI — Denali Therapeutics Inc.

CIK 312069 LONDON, X0

Position in DNLI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,183,421

+$1,183,409 QoQ

Shares Held

84,892

+63.0% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#94

of 290 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,034 across 455 Biotechnology names. DNLI ranks #72 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,183,421	84,892	+63.0%	Shares	Defined	2026-08-14
2026-03-31	$1,000,012	52,084	-87.2%	Shares	Defined	2026-05-15
2025-12-31	$6,725,496	407,359	+25.2%	Shares	Sole	2026-02-13
2022-09-30	$9,988,581	325,467	-11.7%	Shares	Sole	2022-11-03
2022-06-30	$10,852,930	368,771	+534.4%	Shares	Sole	2022-08-12
2022-03-31	$1,870,106	58,132	-51.9%	Shares	Sole	2022-05-16
2021-12-31	$5,388,616	120,821	+70.3%	Shares	Sole	2022-02-14
2021-09-30	$3,580,184	70,965	+198.7%	Shares	Sole	2021-11-09
2021-06-30	$1,863,812	23,761	-73.5%	Shares	Sole	2021-08-13
2021-03-31	$5,126,038	89,773	+299.7%	Shares	Sole	2021-05-13
2020-12-31	$1,881,081	22,458	-22.1%	Shares	Sole	2021-02-11
2020-09-30	$1,032,405	28,814	-19.0%	Shares	Sole	2020-11-12
2020-06-30	$860,541	35,589	+98.0%	Shares	Sole	2020-08-12
2020-03-31	$314,653	17,970	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.